Aviral Singh

Aviral Singh

UNVERIFIED PROFILE

Are you Aviral Singh?   Register this Author

Register author
Aviral Singh

Aviral Singh

Publications by authors named "Aviral Singh"

Are you Aviral Singh?   Register this Author

25Publications

-Reads

Theranostics of prostate cancer: from molecular imaging to precision molecular radiotherapy targeting the prostate specific membrane antigen.

Br J Radiol 2018 Nov 1;91(1091):20180308. Epub 2018 Jun 1.

1 Theranostics Center for Molecular Radiotherapy and Molecular Imaging, Zentralklinik Bad Berka , Bad Berka , Germany.

View Article
November 2018

Pregnancy and Delivery After PRRT Without Sequelae.

Clin Nucl Med 2018 Nov;43(11):842-845

From the THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging, Zentralklinik Bad Berka, Bad Berka, Germany.

View Article
November 2018

Ten-Year Survival After Peptide Receptor Radionuclide Therapy of a Metastatic Well-differentiated G3 Pancreatic Neuroendocrine Neoplasm.

Clin Nucl Med 2018 Sep;43(9):676-678

From the THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging, ENETS Center of Excellence, Zentralklinik Bad Berka, Bad Berka, Germany.

View Article
September 2018

Peptide Receptor Radionuclide Therapy in Grade 3 Neuroendocrine Neoplasms: Safety and Survival Analysis in 69 Patients.

J Nucl Med 2018 Aug 16. Epub 2018 Aug 16.

THERANOSTICS Center for Molecular Radiotherapy & Molecular Imaging, Zentralklinik Bad Berka.

View Article
August 2018

PRRT genomic signature in blood for prediction of Lu-octreotate efficacy.

Eur J Nucl Med Mol Imaging 2018 07 26;45(7):1155-1169. Epub 2018 Feb 26.

LuGenIum Consortium, Milan, Rotterdam, London, Bad Berka, 54 Portland Place, London, W1B1DY, UK.

View Article
July 2018

Results and adverse events of personalized peptide receptor radionuclide therapy with Yttrium and Lutetium in 1048 patients with neuroendocrine neoplasms.

Oncotarget 2018 Mar 15;9(24):16932-16950. Epub 2018 Feb 15.

Department of Gastroenterology/Endocrinology, Center for Neuroendocrine Tumors Bad Berka - ENETS Center of Excellence, Zentralklinik Bad Berka GmbH, Bad Berka, Germany.

View Article
March 2018

Injection of Botulinum Toxin for Preventing Salivary Gland Toxicity after PSMA Radioligand Therapy: an Empirical Proof of a Promising Concept.

Nucl Med Mol Imaging 2018 Feb 11;52(1):80-81. Epub 2018 Jan 11.

1Theranostics Center for Molecular Radiotherapy and Molecular Imaging, Zentralklinik Bad Berka, Bad Berka, Germany.

View Article
February 2018

Theranostics of Neuroendocrine Tumors.

Visc Med 2017 Oct 20;33(5):358-366. Epub 2017 Oct 20.

THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging, ENETS Center of Excellence, Zentralklinik Bad Berka, Bad Berka, Germany.

View Article
October 2017

Theranostic Prospects of Gastrin-Releasing Peptide Receptor-Radioantagonists in Oncology.

PET Clin 2017 Jul 3;12(3):297-309. Epub 2017 Apr 3.

Theranostics Center for Molecular Radiotherapy and Molecular Imaging, Zentralklinik Bad Berka, Bad Berka 99497, Germany.

View Article
July 2017

Morphological and Functional Imaging for Detecting and Assessing the Resectability of Neuroendocrine Liver Metastases.

Neuroendocrinology 2018 21;106(1):74-88. Epub 2017 Jul 21.

Department of Radiology, University Hospitals of Beaujon, Clichy, France.

View Article
July 2017

First-in-Human PET/CT Imaging of Metastatic Neuroendocrine Neoplasms with Cyclotron-Produced Sc-DOTATOC: A Proof-of-Concept Study.

Cancer Biother Radiopharm 2017 May;32(4):124-132

1 Theranostics Center for Molecular Radiotherapy and Molecular Imaging, ENETS Center of Excellence , Zentralklinik Bad Berka, Germany .

View Article
May 2017

Imaging of Prostate Cancer Using Cu-Labeled Prostate-Specific Membrane Antigen Ligand.

PET Clin 2017 Apr 31;12(2):193-203. Epub 2017 Jan 31.

THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging (PET/CT), ENETS Center of Excellence, Zentralklinik Bad Berka, Robert-Koch-Allee 9, Bad Berka 99437, Germany.

View Article
April 2017

PSMA-Based Radioligand Therapy for Metastatic Castration-Resistant Prostate Cancer: The Bad Berka Experience Since 2013.

J Nucl Med 2016 Oct;57(Suppl 3):97S-104S

Theranostics Center for Molecular Radiotherapy and Molecular Imaging, Zentralklinik Bad Berka, Bad Berka, Germany

View Article
October 2016

Advances in the Diagnosis of Neuroendocrine Neoplasms.

Semin Nucl Med 2016 09;46(5):395-404

THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging, ENETS Center of Excellence, Zentralklinik Bad Berka, Bad Berka, Germany. Electronic address:

View Article
September 2016

Peptide receptor radionuclide therapy with (90)Y/ (177)Lu-labelled peptides for inoperable head and neck paragangliomas (glomus tumours).

Eur J Nucl Med Mol Imaging 2015 Jul 31;42(8):1223-30. Epub 2015 Mar 31.

THERANOSTICS Centre for Molecular Radiotherapy and Molecular Imaging, ENETS Center of Excellence, Zentralklinik Bad Berka, Robert Koch Allee, Bad Berka, 99437, Germany.

View Article
July 2015